Literature DB >> 33980027

Specific Abnormalities in White Matter Pathways as Interface to Small Vessels Disease and Cognition in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Individuals.

Heidi I L Jacobs1,2, Dorothee Schoemaker3,4, Hei Torrico-Teave4, Yesica Zuluaga5, Lina Velilla-Jimenez5, Carolina Ospina-Villegas5, Francisco Lopera5, Joseph F Arboleda-Velasquez3, Yakeel T Quiroz4.   

Abstract

Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is characterized by leukoencephalopathy leading to cognitive impairment. Subtle cognitive deficits can be observed early in the course of the disease, before the occurrence of the first stroke. Therefore, markers that can predict disease progression at this early stage, when interventions are likely to alter disease course, are needed. We aimed to examine the biological cascade of microstructural and macrostructural white matter (WM) abnormalities underlying cognitive deficits in CADASIL.
Methods: We examined 20 nondemented CADASIL mutation carriers and 23 noncarriers who underwent neuropsychological evaluation and magnetic resonance imaging. Using probabilistic tractography of key WM tracts, we examined group differences in diffusivity measures and WM hyperintensity volume. Successive mediation models examined whether tract-specific WM abnormalities mediated subtle cognitive differences between CADASIL mutation carriers and noncarriers.
Results: The largest effect size differentiating the two groups was observed for left superior longitudinal fasciculus-temporal (SLFt) diffusivity (Cohen's f = 0.49). No group differences were observed with a global diffusion measure. These specific microstructural differences in the SLFt were associated with higher WM hyperintensities burden, and subtle executive deficits in CADASIL mutation carriers. Discussion: Worse diffusivity in the left SLFt is related to greater severity of small vessel disease and worse executive functioning in the asymptomatic stage of the disease. Worse diffusivity of the left SLFt may potentially hold promise as an indicator of disease progression. Impact statement Diffusion tensor imaging outperforms conventional imaging of subcortical small vessel disease as a potential marker of future disease progression. Here we identified the left superior longitudinal temporal fasciculus as a critical white matter fiber bundle, of which worse diffusivity can link presence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy mutations to greater severity of small vessel disease and worse executive functioning in asymptomatic stages of the disease. This tract may hold promise and deserves further examination as an early indicator of disease progression.

Entities:  

Keywords:  CADASIL; MRI; cognition; diffusion tensor imaging; white matter hyperintensities

Mesh:

Year:  2021        PMID: 33980027      PMCID: PMC8867102          DOI: 10.1089/brain.2020.0980

Source DB:  PubMed          Journal:  Brain Connect        ISSN: 2158-0014


  38 in total

1.  Damage within a network of white matter regions underlies executive dysfunction in CADASIL.

Authors:  M O'Sullivan; T R Barrick; R G Morris; C A Clark; H S Markus
Journal:  Neurology       Date:  2005-11-22       Impact factor: 9.910

2.  Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI.

Authors:  H Chabriat; S Pappata; C Poupon; C A Clark; K Vahedi; F Poupon; J F Mangin; M Pachot-Clouard; A Jobert; D Le Bihan; M G Bousser
Journal:  Stroke       Date:  1999-12       Impact factor: 7.914

Review 3.  Role of NOTCH3 Mutations in the Cerebral Small Vessel Disease Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.

Authors:  Kirsten Coupland; Urban Lendahl; Helena Karlström
Journal:  Stroke       Date:  2018-11       Impact factor: 7.914

Review 4.  Diffusion tensor imaging of cerebral white matter integrity in cognitive aging.

Authors:  David J Madden; Ilana J Bennett; Agnieszka Burzynska; Guy G Potter; Nan-Kuei Chen; Allen W Song
Journal:  Biochim Biophys Acta       Date:  2011-08-16

5.  Patterns of MRI lesions in CADASIL.

Authors:  H Chabriat; C Levy; H Taillia; M T Iba-Zizen; K Vahedi; A Joutel; E Tournier-Lasserve; M G Bousser
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

6.  C455R notch3 mutation in a Colombian CADASIL kindred with early onset of stroke.

Authors:  J F Arboleda-Velasquez; F Lopera; E Lopez; M P Frosch; D Sepulveda-Falla; J E Gutierrez; S Vargas; M Medina; C Martinez De Arrieta; R V Lebo; S A Slaugenhaupt; R A Betensky; A Villegas; M Arcos-Burgos; D Rivera; J C Restrepo; K S Kosik
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

7.  Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis.

Authors:  M O'Sullivan; R G Morris; B Huckstep; D K Jones; S C R Williams; H S Markus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

8.  Spurious group differences due to head motion in a diffusion MRI study.

Authors:  Anastasia Yendiki; Kami Koldewyn; Sita Kakunoori; Nancy Kanwisher; Bruce Fischl
Journal:  Neuroimage       Date:  2013-11-21       Impact factor: 6.556

9.  Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients.

Authors:  Christian Opherk; Nils Peters; Jürgen Herzog; Rainer Luedtke; Martin Dichgans
Journal:  Brain       Date:  2004-09-13       Impact factor: 13.501

10.  Cognitive performance in asymptomatic carriers of mutations R1031C and R141C in CADASIL.

Authors:  Yesica Zuluaga-Castaño; David Andrés Montoya-Arenas; Lina Velilla; Carolina Ospina; Joseph F Arboleda-Velasquez; Yakeel T Quiroz; Francisco Lopera
Journal:  Int J Psychol Res (Medellin)       Date:  2018 Jul-Dec
View more
  1 in total

Review 1.  Cognitive Impairment in Primary and Secondary Headache Disorders.

Authors:  Olivia Begasse de Dhaem; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2022-03-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.